Skip to main content
Swing Capital

Healthcare Global Enterprises Ltd

NSE: HCG BSE: 539787Pharma

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

₹630
52W: ₹512 — ₹800
PE 355 · Book ₹79.3 · +694% vs book
Market Cap₹9,412 Cr
Stock P/E355Price to Earnings
ROCE6.52%Return on Capital
ROE0.14%Return on Equity
Div. Yield0%Face Value ₹10

Weaknesses

  • −Stock is trading at 7.89 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has low interest coverage ratio.
  • −Company has a low return on equity of 2.47% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -7.16%

Shareholding Pattern

Promoters64.21%
FIIs2.76%
DIIs18.91%
Public14.15%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters71.26%71.23%▼0.071.22%▼0.071.22%62.46%▼8.863.78%▲1.363.77%▼0.064.21%▲0.4
FIIs3.95%4.3%▲0.32.77%▼1.52.44%▼0.32.16%▼0.33.59%▲1.43.22%▼0.42.76%▼0.5
DIIs10.89%11.64%▲0.812.94%▲1.312.48%▼0.513.22%▲0.718.36%▲5.118.3%▼0.118.91%▲0.6
Public13.9%12.84%▼1.113.07%▲0.213.86%▲0.822.17%▲8.314.28%▼7.914.71%▲0.414.15%▼0.6

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales282.75285.81299.93293.61329.25312.51324.38327.09345.84342.16
Expenses232.34237.06243.32243.72267.67270.19265.49277.24283.54287.86
Operating Profit50.4148.7556.6149.8961.5842.3258.8949.8562.354.3
OPM %17.83%17.06%18.87%16.99%18.7%13.54%18.15%15.24%18.01%15.87%
Net Profit13.78.67-1.6811.7217.95-37.3310.153.4510.78-1.18
EPS ₹0.930.59-0.110.791.22-2.530.690.230.72-0.08

AI Insights

Revenue Trend

TTM revenue at ₹1,339Cr, up 4.9% YoY. OPM at 17%.

Debt Position

Borrowings at ₹1,008Cr. Debt-to-equity ratio: 0.97x. Moderate leverage.

Capex Cycle

CWIP at ₹58Cr (6% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 18.91% (+12.33pp change). FIIs: 2.76% (-3.71pp change). Promoters hold 64.21%.

Margin & Efficiency

ROCE improving from -2% (Mar 2014) to 7% (Mar 2025). Working capital days: -70.

Valuation

PE 355x with 6.52% ROCE. Price is 694% above book value of ₹79.3. Dividend yield: 0%.

Recent Announcements